- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03323060
Post-Market Clinical Follow-Up to Access & Visualize the Anus, Rectum, & Distal Colon During Transanal Procedures
August 12, 2019 updated by: Medrobotics Corporation
A Multicenter Post-Market Clinical Follow-Up of the Medrobotics Flex Robotic System and Flex Rectoscope Used for Accessing and Visualizing the Anus, Rectum, and Distal Colon During Transanal Procedures
To assess the safety and performance of the Medrobotics Flex Robotic System and Flex Rectoscope for accessing and visualizing the Anus, Rectum, and Distal Colon when used for Transanal procedures
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nevada
-
Las Vegas, Nevada, United States, 89102
- Univsersity of Nevada School of Medicine
-
-
New York
-
New York, New York, United States, 10029
- Icahn School of Medicine at Mount Sinai
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
22 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects ≥ 22 years of age requiring transanal procedures in the areas of the anus, rectum, and distal colon
Description
Inclusion Criteria:
- ≥ 22 years of age
- Candidate for transanal procedures in the areas of the anus, rectum, and distal colon.
Exclusion Criteria:
- Candidates are excluded if they < 22 years of age and do not meet criteria for transanal surgery in the anus, rectum, and distal colon
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Male and/or females ≥ 22 yrs old
≥ 22 years of age requiring transanal procedures in the areas of the anus, rectum, and distal colon Transanal endoscopic surgical procedure
|
Resection of tumors or lesions
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Access and Visualization
Time Frame: 0-24 hours
|
Ability to access/touch with compatible flexible instruments and visualize/see with the scope/camera each of the four anatomical locations in the anus, rectum, and distal colon.
The 4 areas to be accessed/touched and visualized/seen from the most proximal to the most distal are; Lower Rectum, Mid Rectum, Upper Rectum, Rectosigmoid Junction
|
0-24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance of transanal surgical procedure
Time Frame: 0-24 hours
|
Ability to complete the planned transanal surgical procedure using the Flex Robotic System, Flex Rectoscope and Flex compatible flexible instruments
|
0-24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 11, 2017
Primary Completion (Anticipated)
December 30, 2019
Study Completion (Anticipated)
December 30, 2019
Study Registration Dates
First Submitted
October 20, 2017
First Submitted That Met QC Criteria
October 23, 2017
First Posted (Actual)
October 26, 2017
Study Record Updates
Last Update Posted (Actual)
August 13, 2019
Last Update Submitted That Met QC Criteria
August 12, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- FLX-CRC-PMK-US-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disease or Lesions of the Anus, Rectum, or Distal Colon
-
UNC Lineberger Comprehensive Cancer CenterWithdrawnCrossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRIAdvanced Adenocarcinoma of the Colon or RectumUnited States
-
Texas Tech University Health Sciences Center, El...CompletedPancreatic or Peripancreatic Lesions | Lesions in the Esophagus, Stomach, Duodenum or Rectum | Mediastinal ( Chest) Masses | Enlarged Lymph NodesUnited States
-
Baxalta now part of ShireCompletedMalignant Solid Tumors | Metastatic Adenocarcinoma of the Colon or RectumGermany, United States
-
Catholic University of the Sacred HeartUniversity of Amsterdam; Erasme University HospitalCompletedSolid Lesions of the GI Tract or of Adjacent OrgansBelgium, Italy, Netherlands
-
National Cancer Institute (NCI)TerminatedMucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma...United States
-
Kantonsspital LiestalCompletedBenign or Early Malignant Lesion of the Distal Esophagus or Gastro-esophageal Junction Requiring Surgical ResectionSwitzerland
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic or Recurrent Lesions in the Spine | Metastatic or Recurrent Lesions in the PelvisUnited States
-
University of California, DavisNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IIIA Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
-
co.don AGCompletedLarge Articular Cartilage Lesions of the Femoral | Condyle, Trochlea, Tibia or RetropatellarGermany
-
John HaysAmgenCompletedMucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
Clinical Trials on Transanal endoscopic surgical procedure
-
State Scientific Centre of Coloproctology, Russian...UnknownEarly Rectal Cancer | Large Rectal AdenomasRussian Federation
-
Shanghai Minimally Invasive Surgery CenterCompleted
-
Massachusetts General HospitalCompletedAdenocarcinoma of the RectumUnited States
-
Corporacion Parc TauliCompleted
-
Turkish Society of Colon and Rectal SurgeryNot yet recruitingRectal NeoplasmsTurkey
-
Corporacion Parc TauliNot yet recruiting
-
Fundación para el Fomento de la Investigación Sanitaria...Hospital General Universitario ElcheRecruiting
-
European Association for Endoscopic SurgeryWithdrawn
-
Vanderbilt University Medical CenterNational Cancer Institute (NCI)RecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Precancerous ConditionUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...IRCCS Ospedale Casa Sollievo della SofferenzaNot yet recruiting